A comprehensive view of AmerisourceBergen Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AmerisourceBergen reports fiscal year 2022 Q3 GAAP net income up at US$407.0M from US$292.1M a year ago, with revenue up 12.5% year-over-year to US$60.1B; growth driven by 120.3% increase in International Healthcare Solutions revenue

Walgreens raises US$900M from sale of about 6 million shares in pharmaceutical products provider AmerisourceBergen, reducing stake to 25.2% from 28.1%; proceeds will be used to cut debt, support strategic priorities

AmerisourceBergen reports fiscal Q2 attributable net income up 25.9% from a year ago to US$548.0M, with revenue up 17.4% year-over-year to US$57.7B; US revenue up 5.8% year-over-year due to market growth, increased sales to specialty physician practices

AmerisourceBergen partners with Chronicled to use blockchain-powered solution to enhance pharmaceutical chargeback accuracy, reduce rejections; solution will let AB streamline, optimize chargeback process, improve connectivity for suppliers, customers

AmerisourceBergen creates AB Health Ventures venture capital fund to invest in emerging healthcare startups; US$150M fund to focus on pharmacy and distribution, pharmaceuticals, practice solutions for healthcare providers, animal health

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count